Cadagan, D., Khan, R
Figured I should share what my experience was like since starting
External resources FDA concerns with unapproved GLP-1 drugs used for weight loss FBI Internet Crime Complaint Center: safety concerns related to fraudulent compounding practices American Journal of Managed Care: navigating compounded semaglutide PubMed Central: safety and risk assessment of no-prescription online semaglutide purchases In case I do not see you, good afternoon, good evening, and good night
Stability under ICH Q1A/Q1B protocols, with batch-specific CoA and third-party tested documentation, and FDA, EMA, CDSCO, FSSAI-ready dossiers
Enhanced Metabolism and Appetite Control: While semaglutide helps reduce calorie intake by curbing hunger, NAD+ boosts energy metabolism, ensuring that the calories consumed are used efficiently
What that transparency doesn't do is eliminate the category-level considerations every buyer in this space needs to work through in mid-2026: compounded medications aren't FDA-approved, the regulatory environment governing their availability continues to evolve, and the right platform for you depends on your clinical eligibility, state-specific availability, your own health history, and your comfort level with a fully online clinical management model